CanSino Coronavirus Vaccine Shows Promise in Mid-Stage Study

(Bloomberg) -- CanSino Biologics Inc.’s experimental coronavirus vaccine showed promising results in a mid-stage clinical study, paving the way for the next phase of tests as it jostles with Wester...